Non-epilepsy uses of antiepilepsy drugs

Pharmacological Reports

Volumn 58, Issue 1, 2006, Pages 1-12

  Zaremba, Paweł D ^a   Białek, Magdalena ^a   Błaszczyk, Barbara ^b,c   Cioczek, Piotr ^d   Czuczwar, Stanisław J ^a,e  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Neuropsychiatric Hospital Kielce   (Poland)

^c JAN KOCHANOWSKI UNIVERSITY   (Poland)

^d Jan Bozy District Hospital   (Poland)

^e INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Bipolar disorder; Migraine; Neuropathic pain; Neuroprotection

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; LAMOTRIGINE; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PROGABIDE; SODIUM CHANNEL; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ALCOHOLISM; ALLODYNIA; ALZHEIMER DISEASE; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; BINGE EATING DISORDER; BIPOLAR DISORDER; BRAIN ISCHEMIA; CLINICAL TRIAL; COGNITIVE DEFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG USE; ESSENTIAL TREMOR; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERALGESIA; HYPERBILIRUBINEMIA; LIVER TOXICITY; MANIA; MENTAL DISEASE; MIGRAINE; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; PANIC; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL PHOBIA; SPASTICITY; TENSION HEADACHE;

EID: 33646192298     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB: Neuroprotection of the brain during cardiopulmonary bypass in 171 patients. Stroke 1998, 29, 2357-2362.
2. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L et al.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280, 1831-1836.
3. Bannan PE, Graham DI, Lees KR, McCulloch J: Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat. Brain Res. 1994, 664, 271-275.
4. Beers MH, Berkow R: The Merck Manual, Whitehouse Station, N. J, 1999, 2026.
5. Beghi E: The use of anticonvulsants in neurological conditions other than epilepsy. CNS Drugs, 1999, 11, 61-82.
6. Bergouignan M, D'Aulnay M: Effect of diphenyl-hydantoinate salt on essential trigeminal neuralgia. Rev Otoneuroophtalmol, 1951, 23, 427-431.
7. Beydoun A, Kutluay E: Oxcarbazepine. Expert Opin Pharmacother, 2002, 3, 59-71.
8. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E: Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res. 2002, 51, 31-71.
9. Borowicz KK, Piskorska B, Kimber-Trojnar Z, Malek R, Sobieszek G, Czuczwar SJ: Is there any future for felbamate treatment? Pol J Pharmacol, 2004, 56, 289-294.
10. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC et al.: Efficacy of divalproex vs. lithium and placebo in treatment of mania. J Am Med Assoc, 1994, 271, 918-924.
11. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, Pope HG et al.: A randomized, placebo-controlled 12-month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry, 2000, 57, 481-489.
12. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD: A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry, 1999, 60, 79-88.
13. Calabrese JR, Bowden CL, Woyshville MJ: Lithium and anticonvulsants in the treatment of bipolar disorder. In: Psychopharmacology: The Fourth Generation of Progress. Ed. Bloom FE, Kupfer DJ, Raven Press, New York, NY, 1995, 1099-1111.
14. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V et al.: A double-blind, placebo-controlled prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry, 2000, 61, 841-850.
15. Carrazana E. Mikoshiba I: Rationale and evidence for the use of oxcarbazepine in neuropathic pain. J Pain Symptom Manage, 2003, 25, Suppl 5, S31-S35.
16. Chadda VS, Mathur MS: Double blind study of effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India, 1978, 26, 403-406.
17. Chan SA, Reid KH, Schurr A, Miller JJ, Iyer V, Tseng NT: Fosphenytoin reduces hippocampal neuronal damage in rat following transient global ischemia. Acta Neurochir (Wien), 1998, 140, 175-180.
18. Connor GS: A double-blind, placebo-controlled trial of topiramate treatment for essential tremor. Neurology, 2002, 59, 132-134.
19. Czapiński P, Błaszczyk B, Czuczwar SJ: Mechanisms of action of antiepileptic drugs. Curr Topics in Med Chem, 2005, 5, 3-14.
20. Deuschl G, Elbe RJ: The pathophysiology of essential tremor. Neurology, 2000, 54, Suppl, S14-S20.
21. Drewes AM, Andreasen A, Poulsen LH: Valproate for the treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia, 1994, 32, 565-569.
22. Dursun SM, McIntosh D: Clozapine plus lamotrigine in treatment-resistant schizophrenia. Arch Gen Psychiatry, 1999, 56, 950.
23. Dyker AG, Lees KR: Remacemide hydrochloride: a double-blind, placebo-controlled, safety end tolerability study in patients with acute ischemic stroke. Stroke, 1999, 30, 1796-1801.
24. Edwards KR, Glantz MJ, Button J, Norton JA, Whittaker T, Cross N: Efficacy and safety of topiramate in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Neurology, 2000, 54, Suppl, A81.
25. Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J: Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot double-blind, placebo-controlled trials. CNS Spectr, 2003, 8, 428-432.
26. Emrich HM: Studies with oxcarbazepine in acute mania. Int Clin Psychopharmacol, 1990, 5, Suppl, 83-88.
27. Epstein MF, Leviton A, Kuban KC, Pagano M, Meltzer C, Skouteli HN, Brown ER et al. Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies. Pediatrics, 1998, 82, 350-354.
28. Erfurth A, Walden J, Grunze H: Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology, 1998, 38, 204-205.
29. Findley JS, Calzetti S: Double-blind, controlled study of primidone in essential tremor: preliminary results. Br Med J, 1982, 285, 608.
30. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol, 2000, 20, 607-614.
31. Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH: Effects of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 150 water positron emision tomography study. Epilepsia, 1996, 37, 515-521.
32. Gilron I, Booher SL, Rowan JS, Max MB: Topiramate in trigeminal neuralgia: a randomized, placebo-controlled, multiple crossover pilot study. Clin Neuropharmacol, 2001, 24, 109-112.
33. Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascual-Sedano B: A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor. Arch Neurol, 1999, 56, 475-480.
34. Gorman WP, Cooper R, Pocock P, Campbell MJ: A comparison of primidone, propranolol and placebo in essential tremor, using quantitive analysis. J Neurol Neurosurg Psychiatry, 1986, 49, 64-68.
35. Grant SM, Heel RC: Vigabatrin. A review of its pharmacokinetic properties and therapeutic potential in epilepsy and disorders of motor control. Drugs, 1991, 41, 889-926.
36. Gruenthal M, Mueller M, Olson WL, Priebe MM, Sherwood AM, Olson WH: Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord, 1997, 35, 686-689.
37. Hanon E, Klitgaard H: Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure, 2001, 10, 287-293.
38. Henning W, Allen R, Earley C, Kushida C, Picchietti C, Sillier M: The treatment of restless legs syndrome and periodic limb movement disorder. Sleep, 1999, 22, 979-999.
39. Hesslinger B, Klose P, Normann C, Langosch JM, Berger M, Walden J: Zur adjuvanten Behandlung Schizophrener Störungen mit Carbamazepin. Fortschr Neurol Psychiatr, 1998, 66, 145-150.
40. Iacobellis D, Allen R, Lamoureaux L et al.: A double-blind, placebo-controlled trial of pregabalin for the treatment of painful diabetic peripheral neuropathy. Neurology, 2000, 54, Suppl 3, A177.
41. Inglefield JR, Perry JM, Schwartz RD: Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus, 1995, 5, 460-468.
42. Johansen FF, Diemer NH: Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol Scand, 1991, 84, 1-6.
43. Keck PE, McElroy SL, Strakowski SM: Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry, 1998, 59, Suppl 6, 74-81.
44. Kenna GA, McGeary JE, Swift RM: Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment. Part 1. Am J Health Syst Pharm, 2004, 61, 2272-2279.
45. Klapper J: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalgia, 1997, 17, 103-108.
46. Koller WC, Royse VL: Efficacy of primidone in essential tremor. Neurology, 1986, 36, 121-124.
47. Kruger S, Kennedy SH: Psychopharmacotherapy of anorexia nervosa, bulimia nervosa and binge eating disorder. J Psychiatry Neurosci, 2000, 25, 497-508.
48. Leker RR, Neufeld MY: Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Res Rev, 2003, 42, 187-203.
49. Luria Y, Brecker C, Daoud D, Ishay A, Eisenberg E: Lamotrigine in the treatment of painful diabetic neuropathy: a randomized placebo-controlled study. In: Proceedings of 9th World Congress of Pain. Progress in Pain Research and Management. Ed. Devor M, Rowbotham MC, Wiesenfield-Hallinin Z, IASP Press, Seatle, 2000, Vol 16, 857-862.
50. Małek R, Borowicz KK, Kimber-Trojnar Z, Sobieszek G, Piskorska B, Czuczwar SJ: Remacemide - a novel potential antiepileptic drug. Pol J Pharmacol, 2003, 55, 691-698.
51. Margolin A, Avants SK, DePhilips D, Kosten TR: A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse, 1998, 24, 85-101.
52. Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, Stacey B et al.: Efficacy of gabapentin in migraine prophylaxis. Headache, 2001, 41, 119-128.
53. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, Rappaport AM et al.: Migraine prophylaxis with divalproex. Arch Neurol, 1995, 52, 281-286.
54. McElroy SL, Arnold LM, Shapira NA, Keck PE Jr Kamin M, Krim R, Rosenthal N et al.: Topiramate in the treatment of binge eating disorder associated with obesity: a randomized placebo-controlled trial. Am J Psychiatry, 2003, 160, 255-261.
55. McQuay H, Carroll D, Jaddad AR, Wiffen P, Moore A: Anticonvulsant drugs for management of pain: a systematic review. Br Med J, 1995, 311, 1047-1152.
56. Minato H, Kikuta C, Fujyitani B, Masuda Y: Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats. Epilepsia, 1997, 38, 975-980.
57. Morello CM, Leckband SG, Stoner CB: Randomized double blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med, 1999, 59, 1931-1937.
58. Mueller E, Gruenthal M, Olson WL, Olson WH: Gabapentin for relief of upper motor neuron symptoms m multiple sclerosis. Arch Phys Med Rehabil, 1997, 78, 521-524.
59. Muzina DJ, El-Sayegh S, Calabrese JR: Antiepileptic drugs in psychiatry - focus on randomized controlled trial. Epilepsy Res, 2002, 50, 195-202.
60. Nicholson B: Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand, 2000, 101, 359-371.
61. Nicol CF: A four year double-blind study of tegretol in facial pain. Headache, 1969, 9, 54-57.
62. Olesen J: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalgia, 1988, 8, Suppl 7, 1-96.
63. Olson WL, Gruenthal M, Mueller ME, Olson WH: Gabapentin for parkinsonism: a double-blind, placebo-controlled crossover trial. Am J Med, 1997, 102, 60-66.
64. Pahwa, R, Lyons K, Hubble J, Busenbark K, Rienerth JD, Pahwa, A, Koller WC: Double-blind controlled trial of gabapentin in essential tremor. Mov Disord, 1998, 13, 265-467.
65. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G: Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Bipolar disorders II, 2000, 3, 249-255.
66. Pande AC, Davidson JP, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH et al.: Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol, 1999, 19, 341-348.
67. Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB et al.: Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol, 2000, 20,467-471.
68. Peiris JB, Perera GLS, Devendra SV, Lionel ND: Sodium valproate in trigeminal neuralgia. Med J Aust, 1980, 2, 278-279.
69. Potter DL, Hart DE, Calder CS, Storey JR: A double-blind, randomized, placebo-controlled study of topiramate in the prophylactic treatment of migraine with and without aura. Cephalgia, 2000, 20, 305.
70. Pulsinelli WA, Mann ME, Welch KMA: Fosphenytoin in acute ischemic stroke: efficacy results. Neurology, 1999, 52, A 384.
71. Raftery H: The management of postherpetic pain using sodium valproate and amitriptylline. Irish Med J, 1979, 72, 399-401.
72. Rataud J, Debarnot F, Mary V, Pratt J, Stutzmann JM: Comparative study of voltage-sensitive sodium channel blockers in focal ischemia and electric convulsions in rodents. Neurosci Lett, 1994, 172, 19-23.
73. Rice AS, Maton S: Gabapentin in postherpetic neuralgia: a randomized, double-blind, placebo-controlled study. Pain, 2001, 94, 215-224.
74. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller J: Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA, 1998, 280, 1837-1842.
75. Rudick RA, Breton D, Krall RL: The GABA-agonist progabide for spasticity in multiple sclerosis. Arch Neurol, 1987, 44, 1033-1036.
76. Sasso E, Perucca E, Calzetti S: Double-blind comparison of primidone and phenobarbital in essential tremor. Neurology, 1988, 38, 808-810.
77. Saudek CD, Werns S, Reidenberg M: Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther, 1977, 22, 196-199.
78. Schapira AHV: Restless legs syndrome. An update on treatment options. Drugs, 2004, 64, 149-158.
79. Schapira NA, Goldsmith TD, McElroy SL: Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry, 2000, 61, 368-372.
80. Schapiro HM: Barbiturates in brain ischaemia. Br J Anaesth, 1985, 57, 82-95.
81. Schols L, Haan J. Riess O, Amoiridis G, Przuntek H: Sleep disturbance in spinocerebellar ataxias. Neurology, 1998, 51, 1603-1607.
82. Schuaib A, Mahmood RH, Wishart T, Kanthan R, Murabid MA, Ijaz S, Miyashita H: Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioural study. Brain Res, 1995, 702, 199-206.
83. Schuaib A, Waqaar T, Iyaz MS, Kanthan R, Wishat T, Howlett W. Neuroprotection with felbamate: a 7- and 28-day study in transient forebrain ischemia in gerbils. Brain Res, 1996, 727, 65-70.
84. Schwab S, Spranger M, Schwatz S, Hacke W: Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology, 1997, 48, 1608-1613.
85. Serpell M: Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain, 2002, 99, 557-566.
86. Simhandl C, Meszaros K: The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review. J Psychiatry Neurosci, 1992, 17, 1-14.
87. Simpson DM, Olney R, MacArthur JC, Khan A, Godbold J, Ebel-Frommer K: A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology, 2000, 54, 2037-2038.
88. Stewart WF, Shechter A, Rasmussen BK: Migraine prevalence. A review of population-based studies. Neurology, 1994, 44, Suppl 4, S17-S23.
89. Tekin S, Aykut-Bingol C, Tanridag T, Aktan S: Antiglutamatergic therapy in Alzheimer's disease - effects of lamotrigine. J Neural Transm, 1998, 105, 295-303.
90. Thienel U, Neto W, Schwabe SK, Vijapurkar U: Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo controlled trials. Acta Neurol Scand, 2004, 110, 221-331.
91. Thorp ML, Morris CD, Bagby SP: A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis, 2001, 38, 104-108.
92. Tremont-Lukats IW, Megeff C, Beekonja MM: Anti-convulsants for neuropathic pain syndromes: mechanism of action and place in therapy. Drugs, 2002, 60, 1029-1052.
93. Trojnar MK, Małek R, Chrościńska M, Nowak S, Błasczyk B, Czuczwar SJ: Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol, 2002, 54, 557-566.
94. Vajda FJE: Valproate and neuroprotection. J Clin Neurosci, 2002, 9, 508-514.
95. Vartanian MG, Cordon JJ, Kupina NC, Schielke GP, Posner A, Raser KJ, Wang KK et al.: Phenytoin pretreatment prevents hypoxic ischemic brain damage in neonatal rats. Dev Brain Res, 1996, 95, 169-175.
96. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS: Lamotrigine for central post-stroke pain: a randomized controlled trial. Neurology, 2001, 56, 184-190.
97. Ward S, Royal MA, Jenson M: An open label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin. J Pain, 2002, 3, 42.
98. Yang Y, Li Q, Shuaib A: Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology, 2000, 39, 881-888.
99. Yang Y, Shuaib A, Li Q, Siddiqui MM: Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolisation. Brain Res, 1998, 804, 169-176.
100. Yatham LN: Newer anticonvulsants in the treatment of bipolar disorder. J Clin Psychiatry, 2004, 65, Suppl 10, 28-35.
101. Zakrzewska JM, Chaudry Z, Nurmikko U, Patton DW, Mullens EL: Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind, placebo controlled trial. Pain, 1997, 73, 223-230.